Kazia Therapeutics (KZIA) Accumulated Depreciation (2016 - 2018)

Kazia Therapeutics' Accumulated Depreciation history runs 3 years deep, the most recent figure standing at $73.89 for Q4 2018.

• Quarterly Accumulated Depreciation fell 99.95% year-over-year to $73.89 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $73.89 (down 99.95% YoY) and the FY2016 annual result came in at $37384.9, changed N/A from the prior year.
• Accumulated Depreciation was $73.89 for Q4 2018 at Kazia Therapeutics, down from $156425.5 in the prior quarter.
• Across five years, Accumulated Depreciation topped out at $156425.5 in Q4 2017 and bottomed at $73.89 in Q4 2018.
• A 3-year average of $64628.1 and a median of $37384.9 in 2016 frame the typical range for Accumulated Depreciation.
• Annual changes were most pronounced in 2017 — Accumulated Depreciation soared 318.42% — and 2018, when it plunged 99.95%.
• Kazia Therapeutics' Accumulated Depreciation stood at $37384.9 in 2016, then surged by 318.42% to $156425.5 in 2017, then plunged by 99.95% to $73.89 in 2018.
• Business Quant data shows KZIA's Accumulated Depreciation at $73.89 in Q4 2018, $156425.5 in Q4 2017, and $37384.9 in Q4 2016.